ALERT Canadians: Toxic Ingredients in the Arepanrix H1N1 Vaccine Harm Your Health

Health Canada has authorized the sale of Arepanrix™ H1N1 vaccine based on no conclusive clinical testing. The authorization is based on the Health Canada review of available data on the quality, safety and immunogenicity of similar vaccines, which established the benefit/risk profile in favour of inoculating the Canadian population. Continue reading